Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis
- PMID: 19229529
- DOI: 10.1007/s00228-009-0626-7
Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis
Abstract
Background: Resistance to high-dose loop diuretics can be overcome either by co-administration with thiazides or by treatment with medium-dose loop diuretics combined with thiazides. Combination therapy has been proven to be superior to high-dose loop diuretic monotherapy for cardiac and renal edema. However, such a strongly efficacious short-term regimen is often complicated by undesired effects, including circulatory collapse and electrolyte disturbances. The question of whether the loop diuretic/thiazide combinations are efficacious and safe when conventional doses are combined has not yet been answered.
Methods: The effects of hydrochlorothiazide (HCT) and torasemide (TO) given alone on the excretion of Na+, Cl-, K+, Mg2+, and Ca2+ were compared with the effects of combined administration of the diuretics in 12 healthy volunteers.
Results: The co-administration of HCT (25 mg) with TO (5 or 10 mg) strongly increased Na+ excretion. However, the combination significantly reduced K+ and Mg2+ excretion. The K+-sparing effect of the HCT/TO combination was shown to be due to a significant reduction in the HCT-induced increase in fractional K+ excretion by the loop diuretic. Total excretion of Ca2+ relative to Na+ excretion was less with the HCT/TO combination than with TO given alone.
Conclusion: The enhancement of desired NaCl excretion by the HCT/TO combination with significant reduction of undesired loss of K+ and Mg2+ meets clinical requirements but has to be validated in long-term clinical trials.
Similar articles
-
Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:29-44. doi: 10.1007/BF00877956. Cardiovasc Drugs Ther. 1993. PMID: 8435375 Review.
-
Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.Eur J Clin Pharmacol. 1990;39(4):337-43. doi: 10.1007/BF00315406. Eur J Clin Pharmacol. 1990. PMID: 2076714 Clinical Trial.
-
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.Eur J Clin Pharmacol. 2006 Nov;62(11):885-92. doi: 10.1007/s00228-006-0190-3. Epub 2006 Sep 9. Eur J Clin Pharmacol. 2006. PMID: 16964522 Clinical Trial.
-
Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure.Kidney Int. 1994 Aug;46(2):482-8. doi: 10.1038/ki.1994.298. Kidney Int. 1994. PMID: 7967362 Clinical Trial.
-
Torasemide in comparison with thiazides in the treatment of hypertension.Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:63-8. doi: 10.1007/BF00877959. Cardiovasc Drugs Ther. 1993. PMID: 8435378 Review.
Cited by
-
Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action.J Am Heart Assoc. 2017 Oct 5;6(10):e006135. doi: 10.1161/JAHA.117.006135. J Am Heart Assoc. 2017. PMID: 28982672 Free PMC article. Clinical Trial.
-
Acute inhibition of NCC does not activate distal electrogenic Na+ reabsorption or kaliuresis.Am J Physiol Renal Physiol. 2014 Feb 15;306(4):F457-67. doi: 10.1152/ajprenal.00339.2013. Epub 2014 Jan 8. Am J Physiol Renal Physiol. 2014. PMID: 24402096 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous